I want to inject anti-DNGR1 antibody to mouse to block Clec9A receptor on dendritic cells. What would be the difference if I inject it ip vs iv? In the papers I read, usually people are injecting blocking antibodies ip. I wonder why. Is there another reason besides the fact that it is easier to ip inject?

Similar questions and discussions